ITGA5 also functions as the transmembrane receptor, facilitating SPARC-induced ECM changes mediated through fibronectin, which activates fibroblasts to induce dominant ECM alterations that promote tumour cell proliferation and migration in the stroma52,53. The gene discussed is SPARC; the disease is neoplasm.